Sirona Biochem Corp Stock Last Dividend Paid
SRBCF Stock | USD 0.05 0.01 12.50% |
Sirona Biochem Corp fundamentals help investors to digest information that contributes to Sirona Biochem's financial success or failures. It also enables traders to predict the movement of Sirona Pink Sheet. The fundamental analysis module provides a way to measure Sirona Biochem's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Sirona Biochem pink sheet.
Sirona |
Sirona Biochem Corp Company Last Dividend Paid Analysis
Sirona Biochem's Last Dividend Paid refers to dividend per share(DPS) paid to the shareholder the last time dividends were issued by a company. In its conventional sense, dividends refer to the distribution of some of a company's net earnings or capital gains decided by the board of directors.
More About Last Dividend Paid | All Equity Analysis
Last Dividend | = | Last Profit Distribution AmountTotal Shares |
Many stable companies today pay out dividends to their shareholders in the form of the income distribution, but high-growth firms rarely offer dividends because all of their earnings are reinvested back to the business.
Competition |
Based on the recorded statements, Sirona Biochem Corp has a Last Dividend Paid of 0.0. This indicator is about the same for the Biotechnology average (which is currently at 0.0) sector and about the same as Health Care (which currently averages 0.0) industry. This indicator is about the same for all United States stocks average (which is currently at 0.0).
Did you try this?
Run Alpha Finder Now
Alpha FinderUse alpha and beta coefficients to find investment opportunities after accounting for the risk |
All Next | Launch Module |
Sirona Fundamentals
Return On Equity | -35.56 | |||
Return On Asset | -1.35 | |||
Operating Margin | (4.92) % | |||
Current Valuation | 24.5 M | |||
Shares Outstanding | 251.73 M | |||
Shares Owned By Insiders | 10.43 % | |||
Price To Earning | (7.33) X | |||
Price To Book | 36.93 X | |||
Price To Sales | 36.46 X | |||
Revenue | 268.02 K | |||
Gross Profit | 199.25 K | |||
EBITDA | (2.3 M) | |||
Net Income | (2.31 M) | |||
Cash And Equivalents | 1.13 M | |||
Total Debt | 468.77 K | |||
Debt To Equity | 0.60 % | |||
Current Ratio | 2.60 X | |||
Book Value Per Share | 0 X | |||
Cash Flow From Operations | (2.16 M) | |||
Earnings Per Share | (0.01) X | |||
Number Of Employees | 12 | |||
Beta | -0.36 | |||
Market Capitalization | 20.74 M | |||
Total Asset | 1.29 M | |||
Retained Earnings | (12.03 M) | |||
Working Capital | 692 K | |||
Current Asset | 1.49 M | |||
Current Liabilities | 801 K | |||
Z Score | 10.5 | |||
Net Asset | 1.29 M |
About Sirona Biochem Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Sirona Biochem Corp's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Sirona Biochem using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Sirona Biochem Corp based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
Other Information on Investing in Sirona Pink Sheet
Sirona Biochem financial ratios help investors to determine whether Sirona Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Sirona with respect to the benefits of owning Sirona Biochem security.